Bing-Cheng Liu Selected Research

Bing-Cheng Liu Research Topics

3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2018 - 10/2011
3	Leukemia 06/2018 - 04/2009
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2013 - 07/2011
2	Infections 10/2018 - 06/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2013 - 04/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Hemorrhage 02/2020
1	Acute Promyelocytic Leukemia 02/2020
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 06/2019
1	Pulmonary Aspergillosis 10/2018
1	Aspergillosis 10/2018
1	Bacteremia 06/2018
1	Sepsis (Septicemia) 06/2018
1	Septic Shock (Toxic Shock Syndrome) 06/2018
1	Renal Insufficiency (Renal Failure) 02/2015
1	Hepatomegaly 02/2015
1	Splenomegaly 02/2015

1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Imatinib Mesylate (Gleevec)FDA Link 01/2023
1	Arsenic Trioxide (Trisenox)FDA Link 02/2020
1	posaconazole FDA Link 10/2018
1	Voriconazole (Vfend)FDA LinkGeneric 10/2018
1	ProcalcitoninIBA 06/2018
1	Uric Acid (Urate)IBA 02/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2015
1	CreatinineIBA 02/2015
1	Protein Isoforms (Isoforms)IBA 06/2013
1	Core Binding Factors (Core-Binding Factor)IBA 10/2011
1	AntigensIBA 07/2011
1	Sepharose (Agarose)IBA 04/2009

3	Drug Therapy (Chemotherapy) 02/2020 - 04/2012
2	Therapeutics 02/2020 - 02/2015
2	Induction Chemotherapy 02/2015 - 04/2012
1	Stem Cell Transplantation 06/2019
1	Remission Induction 10/2018
1	MDC protocol 04/2015
1	Salvage Therapy 04/2015
1	Combination Drug Therapy (Combination Chemotherapy) 02/2015
1	Transplantation 04/2012